| Limited associations between 5-HT receptor gene polymorphisms and treatment response in antidepressant treatment-free patients with depression T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, ... Frontiers in Pharmacology 10, 1462, 2019 | 20 | 2019 |
| Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: a prospective inception cohort study in treatment-free patients T Ochi, NM Vyalova, IS Losenkov, LA Levchuk, DZ Osmanova, ... Journal of Affective Disorders 259, 432-439, 2019 | 20 | 2019 |
| Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data F Gafar, T Ochi, N Van't Boveneind-Vrubleuskaya, OW Akkerman, ... European Respiratory Journal 56 (4), 2020 | 7 | 2020 |
| Community pharmacist-led interventions in patients with type 2 diabetes in low-income and middle-income countries: A scoping review I Cahyaningsih, M Lambert, T Ochi, F Li, X Li, P Denig, K Taxis Research in Social and Administrative Pharmacy, 2023 | 6 | 2023 |
| Preliminary pharmacogenetic study to explore putative dopaminergic mechanisms of antidepressant action T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, ... Journal of personalized medicine 11 (8), 731, 2021 | 5 | 2021 |
| Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative … LM Geers, T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, ... Human Psychopharmacology: Clinical and Experimental 37 (3), e2826, 2022 | 4 | 2022 |
| Polymorphisms in the adrenergic neurotransmission pathway impact antidepressant response in depressed patients T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, ... Neuroscience Applied 2, 101016, 2023 | 3 | 2023 |
| A new paradigm to indicate antidepressant treatments AJM Loonen, T Ochi, LM Geers, GG Simutkin, NA Bokhan, DJ Touw, ... Pharmaceuticals 14 (12), 1288, 2021 | 2 | 2021 |
| Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation T Ochi, S de Vos, D Touw, P Denig, T Feenstra, E Hak Journal of Diabetes Research 2024, 2024 | 1 | 2024 |
| Learning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels HA Dickinson, J Feifel, K Muylle, T Ochi, E Vallejo-Yagüe Expert Opinion on Drug Safety, 2024 | | 2024 |
| The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness H Dickinson, DY Teltsch, J Feifel, P Hunt, E Vallejo-Yagüe, AV Virkud, ... Drug safety 47 (2), 117-123, 2024 | | 2024 |
| Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens T Ochi, AJ Loonen, GG Simutkin, NA Bokhan, AN Kornetov, SA Ivanova European Psychiatry 66 (S1), S876-S877, 2023 | | 2023 |
| Introducing the Dutch ISPE student chapter M Leung, D Liang, T Ochi, A Bedene, H Gardarsdottir PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 515-515, 2022 | | 2022 |
| Community pharmacist-led interventions and their impacts on patients with type 2 diabetes in low-and middle-income countries: A scoping review I Cahyaningsih, M Lambert, T Ochi, F Li, X Li, P Denig, K Taxis PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 514-514, 2022 | | 2022 |
| Community Pharmacist-Led Interventions in Patients with Type 2 Diabetes in Low-and Middle-Income Countries: A Scoping Review I Cahyaningsih, M Lambert, T Ochi, F Li, X Li, P Denig, K Taxis Authorea Preprints, 2022 | | 2022 |
| Diana Z. Paderina, Ivan V. Pozhidaev, German G. Simutkin, Nikolay A. Bokhan, Bob Wilffert, Daniël J. Touw, Anton JM Loonen, Svetlana A. Ivanova LM Geers, T Ochi, NM Vyalova, IS Losenkov Personalized treatment with psychiatric drugs through Pharmacogenetics and …, 2022 | | 2022 |
| P. 0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, ... European Neuropsychopharmacology 53, S424-S425, 2021 | | 2021 |
| Tailoring type II diabetes treatment: Effect of 5-HTT polymorphism on HbA1c levels after metformin initiation T Ochi, P Denig, H Heerspink, E Hak, B Wilffert PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 437-438, 2020 | | 2020 |
| Limited association between 5-HT receptor gene polymorphisms and treatment response in antidepressant treatment-free patients with depression T Ochi, NM Vyalova, IS Losenkov, DZ Paderina, IV Pozhidaev, A Loonen, ... Naunyn-Schmiedebergs Archives of Pharmacology 393 (Suppl. 1), 18-18, 2020 | | 2020 |
| Emigrants and Immigrants F Gafar, T Ochi, N Van't Boveneind-Vrubleuskaya, OW Akkerman, ... | | 2020 |
